March 6, 2024

Sofia Heigis presented at Stora Aktiedagarna in Stockholm

Sofia Heigis presented Oncopeptides on Tuesday at Stora Aktiedagarna in Stockholm, an event organized by Aktiespararna. The session was held in Swedish.

During her presentation, followed by a question and answer session moderated by Filip Lindkvist from Aktiespararna, Sofia gave an update on the company, focusing on the changing treatment landscape for melflufen and commercialization in Europe with Spain as the latest market.

The presentation along with the Q&A session can be seen in the video below, or via the link Aktiespararna’s recording (YouTube):